Trials / Withdrawn
WithdrawnNCT05991232
Repeated Neurocognitive Measurements in Depressed Patients
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Jay Fournier · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
In this project, we will A) track the functioning of a collection of potential neurobiological targets for depression over time, B) examine how fluctuations in the functioning of those targets relates to real-world functioning, and C) in a subset of the sample, determine how the functioning in those targets is altered by a single dose of ketamine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous Ketamine | Single infusion of intravenous racemic ketamine (0.5mg/kg over 40min) |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2028-04-01
- Completion
- 2029-04-01
- First posted
- 2023-08-14
- Last updated
- 2026-02-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05991232. Inclusion in this directory is not an endorsement.